Suchergebnisse - "Shu, Danhua"

PubPharm (7)

1

Comparative efficacy and tolerability of targeted and immunotherapy combined with chemotherapy as first-line treatment for advanced gastric cancer : a Bayesian network meta-analysis

enthalten in: Scientific reports | 2022

von Liu, S. | Wong, H. | Xie, L. | +7

2

Analysis of human leukocyte antigen associations in human papillomavirus-positive and -negative head and neck cancer : Comparison with cervical cancer

enthalten in: Cancer | 2022

von Ekanayake Weeramange, C. | Shu, D. | Tang, K. | +10

3

Comparative efficacy and tolerability of target agents and immune checkpoint inhibitors in combination with chemotherapy as First-line treatment for advanced gastric cancer: A Bayesian network meta-analysis

enthalten in: ResearchSquare.com | 2022

von Liu, S. | Wong, H. | Xie, L. | +7

4

Analysis of human leukocyte antigen associations in human papillomavirus–positive and –negative head and neck cancer : Comparison with cervical cancer

enthalten in: Cancer | 2022

von Ekanayake Weeramange, C. | Shu, D. | Tang, K. | +10

5

Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years : a case-control study

enthalten in: BMC nephrology | 2017

von Shu, D. | Xu, F. | Su, Z. | +7

6

Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case–control study

enthalten in: BMC nephrology | 2017

von Shu, D. | Xu, F. | Su, Z. | +7

7

Risk factors of progressive IgA nephropathy which progress to end stage renal disease within ten years: a case–control study

enthalten in: BMC nephrology | 2017

von Shu, D. | Xu, F. | Su, Z. | +7

1
[1]